INTRODUCTION
Oxygen dependence of cellular radiosensitivity has been well established for the ionizing radiation, i, e., x or gamma-rays.
Malignant tumors are believed to be composed of two different kinds of cell populations, i, e., aerobic or radiosensitive and hypoxic or less sensitive tumor cells. The experimental animal tumors have been reported to contain large foci of hypoxic cells. Dose-survival curve of multi component cell population such as tumor was obtained by Powers and Tolmach.l) Their data suggest that sterilization of a tumor or tumor control dose (TCD) largely depends on the sensitivity of hypoxic cells and the percentage of hypoxic cell population in the tumor.
The idea that tumor contains large foci of hypoxic cell population was ex tended to human cancer radiotherapy.
Much attention has been focused on hypo xic cells in radiobiology, especially in the tumor radiobiology.
Very recently Hall') suggested that oxygen effect is unimportant in clinical radiotherapy and promoted rethinking of the oxygen effect in human radiotherapy. His idea based on experi mental data reported by Suit et at.') as follows : Hypoxic cells may present in a tumor. However throughout a course of radio therapy (say, given in 30 fractions), such cells might be reoxygenized.
Therefore, originally (i. e., at the begining of radiotherapy) hypoxic cells may not remain oxy gen-deficient throughout the 30 fractions of radiotherapy. In this paper, additional rethinking will be presented whether Hall's idea is barking up the wrong radiotherapeutic tree or not.
DOSE-FRACTIONATION SCHEMA AND TCDp
To sterilize a human tumor, 6,000-7,000 rads are given in 30 fractions in six weeks, or 2,500-3,000 rads might be delivered in rare case as a single fraction . Let us assume that human cancer cell lines have a similar sensitivity as animal tumors or "in vitro" cell lines, and have Do (dose required to reduce survival frac tion of 1/e in the straight portion of multi-target survival curve) of 100-160 rads in aerobic cells and of 300-400 rads in hypoxic cell population with an extrapola tion number or target number (m) of two or three for both cell populations .
If each cells react independently to the ionizing radiation, TCDp (dose required to control p% of irradiated tumors) is a function of radiosensitivity of such cell lines, i, e., m and Do, and of number of cells existing in the tumor (M). The re lationship developed from multi-target survival curve is as follows (3) :
TCDp= Do (In m+ln M-ln In 100) p TCD9o by 30 fractions would be 6,000 rads.
If we further assume that 1% of cells are oxygen-deficient cells (106 cells) with radiosensitivity of Do=300 rads and m=2, 5,000 rads would be required to control 90% of tumors in a single exposure. This is much higher than the clinical dose of 3,000 rads (single exposure).
Cell lines of our assumption (Do is 300 rads and m is 2), are relatively sensitive compared to the hypoxic cells reported.4)
One can realize an inconsistency between these calculations and clinical data, if 108 or 5 x 107 total (viable) cells were estimated in a tumor.
If we assume the presence of this cell number in a tumor, the tumor should contain less hypoxic cells, say 0.001%, i, e., unbelievably small popu lation. If m is three , 10,000 rads are required to obtain 90% probability of tumor control . However, if all the hypoxic cells are reoxygenized during the 30 fractions , TCD90 should be the same as that of 105 well-oxygenated cells (e. g., D0=160 rads) and it might be 6,100 rads (see Fig. 2 for detail.
These data are calculated graphycally according to the dose-response curve of multi-component cell populations such as reported by Powers and Tolmach')). (2) If we assume more practical percentage of hypoxic cells in a tumor, i. e., 1-10%, radiotherapists cannot kill any more than 105 cells out of 108 viable cells in the tumor.
Therefore, there is another question what happened in remaining cells . Are they sterilized by an indirect effect of radiation, e. g., tumor bed effect? Re cent data indicate TD,,, (number of cells expected to induce a tumor in half of the recipients) is the same in both normal and previously irradiated tumor beds-) . Are they killed by some other factors, e. g., immunologic reaction ? Do they have a division probability of less than one') ? (In this case one can more easily solve this inconsistency than the other situations assumed.)
Or are they just sleeping in ? Lethally irradiated cells which have a stimulating effect to viable tumor cells when they were transplanted in the admixture with viable cells'), make this in consistency more complexed. Our recent study') indicates that nearly one cell or very few cells might be enough to induce recurrence after the radiotherapy. Therefore, the effect of lethally irradiated cells cannot explain this inconsistency. Reoxygenation of oxygen-deficient cell population is now well established in several studies of animal tumors.8,9,10> In human cancer, hypoxic cells might be reoxygenized throughout the radiotherapy. One could realize that almost all the considerations in this paper are based on several assumptions. That means, be fore we give a conclusion, more experimental and clinical data should be required as pointed out by A1per.1) It should contain detailed data for division probability of sublethally irradiated cells and of not-irradiated tumor cells. Repair capability of sublethally irradiated cells which were hypoxic at the time irradiated and were in "the tumor" would be another one.
number.
If radiation is given in v fractions and each fractionated dose comprises of an equal dose of D/v which is given after the complete cellular recovery from the sublethal damage, the surviving fraction of the cell will be :
S.= {1 (1-e-DI/Do)m} Probability of the cell death after the fractionated doses : Pv=1-Sy If M cells are contained in a tumor and each cell responds to radiation inde pendently, probability of killing M cells (P) is given in an equation ; P= (1-S.) M If it is assumed that one surviving cell or one cell with the reproductive in tegrity can produce tumor regrowth, or that all tumor cells are required to receive the lethal radiation damage for the tumor cure, TCDP will be solved in following formula.
